CA2646425C - Novel poly(ethylene oxide)-block-poly(ester) block copolymers - Google Patents

Novel poly(ethylene oxide)-block-poly(ester) block copolymers Download PDF

Info

Publication number
CA2646425C
CA2646425C CA2646425A CA2646425A CA2646425C CA 2646425 C CA2646425 C CA 2646425C CA 2646425 A CA2646425 A CA 2646425A CA 2646425 A CA2646425 A CA 2646425A CA 2646425 C CA2646425 C CA 2646425C
Authority
CA
Canada
Prior art keywords
alkyl
formula
compound
peo
integer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2646425A
Other languages
English (en)
French (fr)
Other versions
CA2646425A1 (en
Inventor
Afsaneh Lavasanifar
Abdullah Mahmud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alberta
Original Assignee
University of Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Alberta filed Critical University of Alberta
Priority to CA2857023A priority Critical patent/CA2857023C/en
Publication of CA2646425A1 publication Critical patent/CA2646425A1/en
Application granted granted Critical
Publication of CA2646425C publication Critical patent/CA2646425C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/04—Seven-membered rings not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • C08G63/664—Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
    • C08G2261/10—Definition of the polymer structure
    • C08G2261/12—Copolymers
    • C08G2261/126—Copolymers block

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyethers (AREA)
CA2646425A 2006-03-21 2007-03-21 Novel poly(ethylene oxide)-block-poly(ester) block copolymers Active CA2646425C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2857023A CA2857023C (en) 2006-03-21 2007-03-21 Novel poly(ethylene oxide)-block-poly(ester) block copolymers

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78383706P 2006-03-21 2006-03-21
US60/783,837 2006-03-21
PCT/CA2007/000451 WO2007106997A1 (en) 2006-03-21 2007-03-21 Novel poly(ethylene oxide)-block-poly(ester) block copolymers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2857023A Division CA2857023C (en) 2006-03-21 2007-03-21 Novel poly(ethylene oxide)-block-poly(ester) block copolymers

Publications (2)

Publication Number Publication Date
CA2646425A1 CA2646425A1 (en) 2007-09-27
CA2646425C true CA2646425C (en) 2014-11-04

Family

ID=38521977

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2646425A Active CA2646425C (en) 2006-03-21 2007-03-21 Novel poly(ethylene oxide)-block-poly(ester) block copolymers
CA2857023A Active CA2857023C (en) 2006-03-21 2007-03-21 Novel poly(ethylene oxide)-block-poly(ester) block copolymers

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2857023A Active CA2857023C (en) 2006-03-21 2007-03-21 Novel poly(ethylene oxide)-block-poly(ester) block copolymers

Country Status (5)

Country Link
US (2) US8309515B2 (cg-RX-API-DMAC7.html)
EP (2) EP2730604B1 (cg-RX-API-DMAC7.html)
JP (1) JP5933889B2 (cg-RX-API-DMAC7.html)
CA (2) CA2646425C (cg-RX-API-DMAC7.html)
WO (1) WO2007106997A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008071009A1 (en) * 2006-12-15 2008-06-19 The Governors Of The University Of Alberta Novel ligand guided block copolymers for targeted drug delivery
WO2010127271A1 (en) 2009-04-30 2010-11-04 Intezyne Technologies, Incorporated Polymer micelles containing anthracylines for the treatment of cancer
US8524784B2 (en) * 2009-04-30 2013-09-03 Intezyne Technologies, Incorporated Polymer micelles containing anthracylines for the treatment of cancer
US8361495B2 (en) * 2009-12-23 2013-01-29 International Business Machines Corporation Antimicrobial polymers and methods of manufacture thereof
US8470891B2 (en) * 2009-12-23 2013-06-25 International Business Machines Corporation Biodegradable block polymers for drug delivery, and methods related thereto
US9975983B2 (en) * 2014-10-15 2018-05-22 University Of Connecticut Bio-reducible self-assembled liquid crystalline block copolymer for drug delivery
US10828371B2 (en) 2017-11-08 2020-11-10 International Business Machines Corporation Multifunctionalized bioactive polycaprolactone
AU2018384096B2 (en) * 2017-12-12 2021-04-15 Cardiol Therapeutics Inc. Amphiphilic block copolymers, micelles, and methods for treating or preventing heart failure
EP3699175B1 (en) 2019-02-19 2022-05-04 Kemijski Institut Functionalized aliphatic polyesters and process for producing the same
FI129022B (en) * 2019-09-10 2021-05-14 Aabo Akademi Univ Polymer and composition made from a renewable source
JP7641003B2 (ja) * 2021-06-02 2025-03-06 国立大学法人金沢大学 蛍光プローブ、液相の極性及び粘性を評価する方法、並びに化合物
KR102663816B1 (ko) * 2021-10-26 2024-05-14 전북대학교산학협력단 중합 후 변성법을 이용한 기능성 폴리에틸렌글리콜의 합성방법

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2790818A (en) 1954-09-23 1957-04-30 Monsanto Chemicals Cyanoethylation of organic sulfur compounds
US2792425A (en) 1954-10-14 1957-05-14 Monsanto Chemicals Production of hydroperoxides using malonic esters as oxidation initiators
US3670045A (en) * 1970-12-30 1972-06-13 Union Carbide Corp Aba block polymers of polylactones and polyethers
HU167366B (cg-RX-API-DMAC7.html) 1972-09-06 1975-09-27
JPS5626929A (en) * 1979-08-09 1981-03-16 Research Corp Betaamalolactone polymer and medical material
JPS57131779A (en) 1981-02-10 1982-08-14 Dainippon Ink & Chem Inc Preparation of alpha-acetyllactone
JPS58103379A (ja) 1981-12-14 1983-06-20 Dainippon Ink & Chem Inc α−アセチルラクトン類の製造方法
JPS58162585A (ja) 1982-03-19 1983-09-27 Dainippon Ink & Chem Inc α−アシルラクトン類の製造方法
JPS58180493A (ja) 1982-04-14 1983-10-21 Dainippon Ink & Chem Inc エノ−ルシリルエ−テル類の製造方法
JPS6016989A (ja) * 1983-07-06 1985-01-28 Shionogi & Co Ltd オキソ飽和異項環カルボンアミドセフエム化合物
GB8811024D0 (en) 1988-05-10 1988-06-15 Shell Int Research Process for preparation of lactones from higher alkenols
CA1336980C (en) * 1988-05-10 1995-09-12 Eit Drent Process for the preparation of lactones
CA2066876C (en) * 1991-06-06 1999-12-14 Matthew B. Hoyt Acid-dye resistant polyamide products and process for preparation
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
US5801224A (en) * 1996-04-26 1998-09-01 Board Of Trustees Operating Michigan State University Bulk reactive extrusion polymerization process producing aliphatic ester polymer compositions
AU5907898A (en) * 1997-01-13 1998-08-03 Penn State Research Foundation, The Asymmetric synthesis and catalysis with chiral heterocyclic compounds
GB9809116D0 (en) 1998-04-29 1998-07-01 Zeneca Ltd Ether/ester dispersants
JP2000004892A (ja) * 1998-06-29 2000-01-11 Toyo Ink Mfg Co Ltd ポリエステル−ポリエーテルブロック共重合体の製造方法
US6469132B1 (en) 1999-05-05 2002-10-22 Mcgill University Diblock copolymer and use thereof in a micellar drug delivery system
EP1178031B1 (en) 2000-03-10 2012-02-01 Daicel Chemical Industries, Ltd. Process for the preparation of organic compounds with manganese catalysts or the like
JP2002351066A (ja) 2001-05-30 2002-12-04 Fuji Photo Film Co Ltd 赤外線レーザー用ポジ型平版印刷版材料及び処理方法
EP1539852B1 (en) * 2002-09-05 2007-05-30 Vocfree, Inc. Fast drying coatings
JP4800927B2 (ja) * 2003-03-04 2011-10-26 フイルメニツヒ ソシエテ アノニム ラクトンまたはエポキシドの製造方法
CA2523987C (en) * 2003-10-10 2009-08-04 Samyang Corporation Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery
JP2005139068A (ja) * 2003-11-04 2005-06-02 Sumitomo Chemical Co Ltd α―アセチル−γ―ブチロラクトン誘導体の製造方法
US20070086975A1 (en) * 2003-12-17 2007-04-19 Francis Ignatious Polymeric micellar complexes and drug delivery vehicles thereof
JP2007519756A (ja) * 2004-01-30 2007-07-19 アンジオテック インターナショナル アーゲー 拘縮を治療するための組成物および方法
CA2580305A1 (en) * 2004-06-02 2005-12-15 The Governors Of The University Of Alberta Polymer based nano-carriers for the solubilization and delivery of hydrophobic drugs
JP4553374B2 (ja) * 2004-06-11 2010-09-29 キヤノン株式会社 スルホン酸基を有するポリヒドロキシアルカノエート並びにその製造方法
US20080124400A1 (en) 2004-06-24 2008-05-29 Angiotech International Ag Microparticles With High Loadings Of A Bioactive Agent
WO2008071009A1 (en) * 2006-12-15 2008-06-19 The Governors Of The University Of Alberta Novel ligand guided block copolymers for targeted drug delivery

Also Published As

Publication number Publication date
EP1994081A1 (en) 2008-11-26
EP2730604A2 (en) 2014-05-14
EP1994081A4 (en) 2010-11-10
WO2007106997A1 (en) 2007-09-27
EP1994081B1 (en) 2014-05-21
CA2646425A1 (en) 2007-09-27
US20130116428A1 (en) 2013-05-09
EP2730604B1 (en) 2018-10-24
CA2857023A1 (en) 2007-09-27
CA2857023C (en) 2016-10-11
US20100069295A1 (en) 2010-03-18
US9139553B2 (en) 2015-09-22
JP2009530447A (ja) 2009-08-27
JP5933889B2 (ja) 2016-06-15
EP2730604A3 (en) 2014-05-28
US8309515B2 (en) 2012-11-13

Similar Documents

Publication Publication Date Title
CA2857023C (en) Novel poly(ethylene oxide)-block-poly(ester) block copolymers
Tang et al. Block copolymer micelles with acid-labile ortho ester side-chains: synthesis, characterization, and enhanced drug delivery to human glioma cells
Nabid et al. Self-assembled micelles of well-defined pentaerythritol-centered amphiphilic A4B8 star-block copolymers based on PCL and PEG for hydrophobic drug delivery
Shahin et al. Novel self-associating poly (ethylene oxide)-b-poly (ɛ-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery
KR100829799B1 (ko) 양친성 블록 공중합체 및 폴리락트산 유도체를 포함하는 고분자 약물 담체에 기초한 생물 활성제의 세포내 전달용 조성물
US20100137206A1 (en) Novel ligand guided block copolymers for targeted drug delivery
Cao et al. Effect of architecture on the micellar properties of poly (ɛ-caprolactone) containing sulfobetaines
Kim et al. Novel pH-sensitive polyacetal-based block copolymers for controlled drug delivery
Lee et al. Ketal containing amphiphilic block copolymer micelles as pH-sensitive drug carriers
Tao et al. Synthesis of cholic acid-core poly (ε-caprolactone-ran-lactide)-b-poly (ethylene glycol) 1000 random copolymer as a chemotherapeutic nanocarrier for liver cancer treatment
CN103599548B (zh) 一种紫杉醇高分子键合药及其制备方法
JP6165920B2 (ja) 活性成分のポリマーコンジュゲート、その製造方法及びそのポリマー中間体
Sedghi et al. Divergent synthesis of dendrimer-like pH-responsive macromolecules through a combination of ATRP and ROP for controlled release of anti-cancer drug
CN109134870A (zh) 一种pH响应聚合物载体及其制备的胶束、制备方法和应用
Lin et al. Thermosensitive in situ hydrogel of paclitaxel conjugated poly (ε-caprolactone)-poly (ethylene glycol)-poly (ε-caprolactone)
Mane et al. Stimuli responsive nanocarrier for an effective delivery of multi-frontline tuberculosis drugs
Wu et al. Synthesis and micellization of a new amphiphilic star-shaped poly (D, L-lactide)/polyphosphoester block copolymer
Chen et al. Comparative study of linear polyglycidol acylhydrazones and curcumin conjugates: Surface activity and targeted antitumor drug delivery
KR100492805B1 (ko) 안정성이 향상된 고분자 미셀 조성물
JP6940519B2 (ja) 親水性ポリエステル及びそのブロックコポリマー
CN107922559B (zh) 用于药物递送的生物可还原的自装配液晶嵌段共聚物
Yang et al. Hollow organic/inorganic hybrid nanoparticles from dextran-block-polypeptide copolymer: double click reaction synthesis and properties
CN109054010A (zh) 一种咪唑环修饰的酸敏感聚碳酸酯材料及其制备和应用
Kakde Synthesis, characterisation and applications of new polyesters for drug delivery
Sardar Study of the physico-chemical properties of macromolecular assemblies

Legal Events

Date Code Title Description
EEER Examination request
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 18TH ANNIV.) - SMALL

Year of fee payment: 18

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250314

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250314

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250314

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 19TH ANNIV.) - SMALL

Year of fee payment: 19

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260107

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260107